- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 215/18 - Halogen atoms or nitro radicals
Patent holdings for IPC class C07D 215/18
Total number of patents in this class: 312
10-year publication summary
|
13
|
17
|
13
|
23
|
30
|
17
|
16
|
11
|
11
|
0
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 5080 |
18 |
| IntelGenx Corp. | 69 |
10 |
| Merck Patent GmbH | 5909 |
7 |
| CHDI Foundation, Inc. | 104 |
7 |
| Synthon BV | 308 |
7 |
| Gilead Sciences, Inc. | 1879 |
6 |
| F. Hoffmann-La Roche AG | 7958 |
5 |
| Matrix Laboratories Limited | 123 |
5 |
| Bayer Cropscience AG | 2241 |
4 |
| Dow Global Technologies LLC | 10147 |
4 |
| Akaal Pharma Pty Ltd. | 11 |
4 |
| The Regents of the University of California | 18943 |
3 |
| Janssen Pharmaceutica N.V. | 3839 |
3 |
| Monsanto Technology LLC | 7905 |
3 |
| The Regents of the University of Michigan | 4409 |
3 |
| Dr. Reddy's Laboratories, Inc. | 207 |
3 |
| Dr. Reddy's Laboratories Limited | 551 |
3 |
| Esteve Quimica, S.A. | 29 |
3 |
| Glade Organics Private Limited | 6 |
3 |
| Hanmi Pharm. Co., Ltd. | 546 |
3 |
| Other owners | 208 |